These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 13988687)

  • 1. Comparison between the one-stage prothrombin time and factor VII and X complex determination in bishydroxycoumarin-induced hypoprothrombinemia countered by phytonadione.
    SHOSHKES M; ODZE M; JACOBS ML
    J Newark Beth Isr Hosp; 1963 Jan; 14():32-6. PubMed ID: 13988687
    [No Abstract]   [Full Text] [Related]  

  • 2. Orally administered phytonadione in bishydroxycoumarin-induced hypoprothrombinemia.
    SHOSHKES M; ROBINS B; YELIN G
    J Am Med Assoc; 1957 Sep; 165(4):330-3. PubMed ID: 13462790
    [No Abstract]   [Full Text] [Related]  

  • 3. THE EFFECT OF DICUMAROL ON PROTHROMBIN TIME IN RATS AND ITS RELATION TO VITAMIN K CONTENT OF LIVER.
    CHANDRASEKHAR N; HICKIE RA; MILLAR GJ
    Can J Physiol Pharmacol; 1965 Jul; 43():639-47. PubMed ID: 14329349
    [No Abstract]   [Full Text] [Related]  

  • 4. EFFECT OF ORAL ANTICOAGULANTS ON FACTORS VII, IX, X, AND II.
    KAZMIER F; SPITTELL JA; THOMPSON JJ; OWEN CA
    Arch Intern Med; 1965 Jun; 115():667-73. PubMed ID: 14299436
    [No Abstract]   [Full Text] [Related]  

  • 5. Antagonistic and antidotal action of vitamins K1 and K3 versus dicumarol in dogs.
    Millar GJ; Henriet M; Jaques LB
    Proc Soc Exp Biol Med; 1965; 119(4):1093-7. PubMed ID: 4158157
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of the thrombotest with the modified Quick test. Drug-induced hypoprothrombinemia countered with phytonadione.
    SHOSHKES M; ODZE M
    Circulation; 1963 Jul; 28():58-62. PubMed ID: 13988686
    [No Abstract]   [Full Text] [Related]  

  • 7. THE SEPARATION OF AUTOPROTHROMBIN I-C FROM BOVINE PROTHROMBIN PREPARATIONS.
    SEEGERS WH; KAGAMI M
    Can J Biochem; 1964 Sep; 42():1249-62. PubMed ID: 14217232
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies regarding the effect of foreign-surface contact on the one-stage prothrombin time determination.
    Shanberge JN; Matsuoka T
    Thromb Diath Haemorrh; 1966 May; 15(3):442-50. PubMed ID: 5989030
    [No Abstract]   [Full Text] [Related]  

  • 9. THROMBOPLASTIC ACTIVITY OF HUMAN SALIVA IN PATIENTS UNDER PROLONGED ANTICOAGULATION THERAPY.
    DOKU HC; TAYLOR RG; SISE HS; BECKER R
    J Dent Res; 1964; 43():323-30. PubMed ID: 14159035
    [No Abstract]   [Full Text] [Related]  

  • 10. A COMPARISON OF BISHYDROXYCOUMARIN AND WARFARIN SODIUM IN TERMS OF COAGULATION FACTOR CHANGES AND BLEEDING COMPLICATIONS.
    FREMONT RE; WIEDMAN M; LUBELL D
    Am J Med Sci; 1963 Sep; 246():265-76. PubMed ID: 14063743
    [No Abstract]   [Full Text] [Related]  

  • 11. Behaviour of factors II, VII, IX and X during long-term treatment with coumarin.
    LOELIGER EA; van der ESCH ; MATTERN MJ; den BRABANDER AS
    Thromb Diath Haemorrh; 1963 Apr; 9():74-89. PubMed ID: 13931274
    [No Abstract]   [Full Text] [Related]  

  • 12. STUDIES ON PROCONVERTIN (FACTOR VII).V. BIOSYNTHESIS IN SUSPENSION CULTURES OF RAT LIVER CELLS.
    PRYDZ H
    Scand J Clin Lab Invest; 1964; 16():540-8. PubMed ID: 14209214
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of synthetic vitamin K1 on prothrombin, factor VII complex and factor IX in premature infants].
    YOSHIDA K; MORII N; KANMI M; YOSHIDA K
    Paediatr Jpn; 1963 Jun; 67():373-8. PubMed ID: 14002672
    [No Abstract]   [Full Text] [Related]  

  • 14. The treatment of dicumarol-induced hypoprothrombinemia in dogs with emulsified vitamin K1 administered intravenously.
    SHOSHKES M; GEYER RP; YEE GS; STARE FJ
    J Lab Clin Med; 1950 Oct; 36(4):531-6. PubMed ID: 14779068
    [No Abstract]   [Full Text] [Related]  

  • 15. Effectiveness of synthetic water-soluble vitamin K preparations in bishydroxycoumarin-induced hypoprothrombinemia.
    OVERMAN RS; SORENSON CW; WRIGHT IS
    J Am Med Assoc; 1951 Feb; 145(6):393-9. PubMed ID: 14794454
    [No Abstract]   [Full Text] [Related]  

  • 16. [Preventive effect of menaquinone-4 (K2) on hypoprothrombinemia caused by dicumarol].
    Tajima T; Kawashima H; Kato Y; Ogo T; Miyao K
    Nihon Yakurigaku Zasshi; 1971 Jul; 67(4):419-30. PubMed ID: 4107009
    [No Abstract]   [Full Text] [Related]  

  • 17. The treatment of dicumarol-induced hypoprothrombinemia in man with emulsified vitamin K1 administered intravenously.
    WATKIN DM; VAN ITALLIE TB; LOGAN WB; GEYER RP; DAVIDSON CS; STARE FJ
    J Lab Clin Med; 1951 Feb; 37(2):269-71. PubMed ID: 14814353
    [No Abstract]   [Full Text] [Related]  

  • 18. [PRIMARY IDIOPATHIC HYPERACTIVITY OF PROTHROMBIN AND FACTOR VII].
    GAY A; ALZETTA A; MONTALE P
    Arch Maragliano Patol Clin; 1963 Dec; 19():785-91. PubMed ID: 14120627
    [No Abstract]   [Full Text] [Related]  

  • 19. Hypoprothrombinemia in patients with cancer receiving cefoperazone and mezlocillin.
    Jones PG; Strother SV; Rolston KV; Fainstein V; Bodey GP
    Arch Intern Med; 1986 Jul; 146(7):1397-9. PubMed ID: 3521526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A COMPARISON OF WARFARIN SODIUM AND BISHYDROXYCOUMARIN IN LONG-TERM ANTICOAGULANT THERAPY.
    BROWN KW; MACMILLAN RL
    Can Med Assoc J; 1964 Dec; 91(26):1358-9. PubMed ID: 14230912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.